Francois Guillonneau

Title: The Innovative Contributions of Francois Guillonneau

Introduction

Francois Guillonneau is a notable inventor based in Droue/Drouette, France. He has made significant contributions to the field of neonatal serological diagnosis. His work focuses on improving the early detection of diseases transmitted from mother to child.

Latest Patents

Guillonneau holds a patent for a method of neonatal serological diagnosis. This invention provides a method for determining the amino acid polymorphisms of the heavy gamma chain of immunoglobulins G through a proteomic approach. The method effectively distinguishes between the immunoglobulins of the mother and those of the newborn in a blood sample obtained during the first months of the child's life. Additionally, the invention relates to the early diagnosis of vertically transmitted diseases in neonates. It also includes peptides distinctive of G3m and IGHG3 alleles, along with a kit comprising these peptides. He has 1 patent to his name.

Career Highlights

Throughout his career, Guillonneau has worked with esteemed organizations such as the Institut de Recherche pour le Développement (IRD) and Université Paris Descartes. His experience in these institutions has contributed to his expertise in immunology and neonatal health.

Collaborations

Guillonneau has collaborated with notable colleagues, including Florence Migot-Nabias and Celia Dechavanne. These partnerships have furthered his research and development efforts in the field.

Conclusion

Francois Guillonneau's innovative work in neonatal serological diagnosis showcases his commitment to advancing medical science. His contributions are vital for improving early disease detection in newborns, ultimately benefiting public health.